Streetbeat News

Products Services

EA

Benchmark analyst Mike Hickey reiterated a Buy rating and a $153 price target for Electronic Arts Inc (EA). Despite concerns over Apex Legends' growth, Hickey remains cautiously optimistic about EA's upcoming 2Q24 financial results. Key releases in the quarter included EA Sports FC 24 and Madden NFL 24, with EA Sports FC 24 showing strong launch numbers. However, the decision to remove FIFA 23 from digital stores before the launch of EA Sports FC could impact catalog sales. Hickey projects Q2 revenue of $1.70 billion vs. consensus $1.77 billion and EPS of $1.09 vs. consensus $1.25.

Portfolio Pulse from Anusuya Lahiri

October 10, 2023 | 6:05 pm

AKRO

CRBU

MRNA

MYNZ

PFE

Mainz Biomed N.V. (NASDAQ:MYNZ) has developed ColoAlert, the first DNA-based screening test for colorectal cancer in Europe, and is also developing a proprietary genetic testing method for pancreatic cancer. Pfizer Inc (NYSE:PFE) has invested $25 million in Caribou Biosciences (NASDAQ:CRBU) and Akero Therapeutics Inc (NASDAQ:AKRO), while Moderna Inc (NASDAQ:MRNA) reported positive Phase 1/2 data from its combination vaccine against both Influenza and Covid-19.

Portfolio Pulse from Upwallstreet

October 10, 2023 | 5:53 pm

SMPL

Needham analyst Matt McGinley reiterated a Buy rating on The Simply Good Foods Company (NASDAQ:SMPL) with a price target of $42. The analyst expects strong topline growth in 4QF24 due to inventory rebuild, despite soft Atkins sell-thru in 2HFY23. Quest’s health composition of 55% sales remains healthy and is expected to drive SMPL's 4-6% long-term topline growth. The analyst warned that if Atkins' volume remains negative, it risks the growth until these issues are remedied. SMPL's growth profile is considered attractive among its food manufacturing peers.

Portfolio Pulse from Shivani Kumaresan

October 10, 2023 | 5:43 pm

OTEX

OpenText (NASDAQ: OTEX) has announced its new unified OpenText Partner Network, which combines OpenText's and recently acquired Micro Focus' partner ecosystems. The network will provide over 30,000 partners with access to OpenText's expertise in information management. The company is investing in R&D to develop advanced technologies for partners to build upon. The new network includes programs for enterprise partners, mid-market partners, and a program for partners to build custom solutions using OpenText Cloud API services.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 5:42 pm

AAPL

Analyst Ming-Chi Kuo predicts that the 2024 Apple Watch will not adopt Micro LED, and the 2025 model may use it. Apple Watch shipments in 2023 are expected to decline by 15% YoY to 36–38 million units. The highly anticipated blood glucose monitoring feature won't be introduced in 2024 or possibly 2025. Kuo suggests that the Apple Watch may need to be repositioned if there's a YoY decline again in 2024.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 5:41 pm

WMT

Walmart Inc. (NYSE:WMT) is expanding its virtual primary care services, allowing employees and their families to develop long-term relationships with doctors across the country. The company launched a pilot in three states in 2020 and expanded it to 21 states in 2023 after seeing success. The service has led to a decrease in medical costs by about 10%. Included Health will provide the expanded online access from Oct. 14. The move is expected to be a 'big test' of how much treatment can shift to the internet.

Portfolio Pulse from Nabaparna Bhattacharya

October 10, 2023 | 5:29 pm

SPCE

Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares are recovering from a recent downward trend, trading nearly 15% higher on Tuesday. This comes after the company announced the completion of its fifth successful human space mission in five months. Despite the rise, the stock remains down more than 24% over the last month.

Portfolio Pulse from Erica Kollmann

October 10, 2023 | 5:20 pm

AAPL

Apple has released a software update for iPhone 12 users in France that turns off the off-body detection feature to accommodate ANFR's test protocol.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 5:08 pm

CRDL

Cardiol Therapeutics Inc. (NASDAQ:CRDL) announced positive study results showing that its novel CRD-38 subcutaneous formulation, which contains cannabidiol, slowed increases in body weight and heart weight, and prevented increases in key cardiac inflammatory and remodeling markers in a model of heart failure with preserved ejection fraction (HFpEF). The study was presented at the Heart Failure Society of America Annual Scientific Meeting 2023. The findings suggest new therapeutic potential in HFpEF, a leading cause of death and hospitalization in the US and the developed world. Cardiol Therapeutics' shares traded 12.5218% higher at $0.9013 per share following the announcement.

Portfolio Pulse from Jelena Martinovic

October 10, 2023 | 4:57 pm

GM

General Motors' unit, GM Defense, has partnered with Anduril Industries to collaborate on a defense program. The companies will focus on delivering autonomy solutions, battery electrification, and other new propulsion technologies. The announcement aligns with the Association of the U.S. Army tradeshow where both companies are showcasing variations of the Infantry Squad Vehicle (ISV).

Portfolio Pulse from Nabaparna Bhattacharya

October 10, 2023 | 4:53 pm